Fibrin(ogen)olytic character of FIIa isolated from Agkistrodon acutus venom

Acta Pharmacologica Sinica

Volumn 26, Issue 6, 2005, Pages 691-695

  Wang, Yi Wen ^a   Liang, Xiu Xia ^a   Chen, Jia Shu ^a   Chen, Qi ^a   Qiu, Peng Xin ^a   Lin, Xi ^a   Yan, Guang Mei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Agkistrodon acutus; Carotid artery thrombosis; Fibrinolysis; Snake venoms; Urokinase

Indexed keywords

ACUTIN; FIBRIN; FIBRINOGEN; FIBRINOLYTIC AGENT; PROTHROMBIN A; SNAKE VENOM; UNCLASSIFIED DRUG; UROKINASE;

ADOLESCENT; AGKISTRODON; AGKISTRODON ACUTUS; ANIMAL MODEL; ARTICLE; BLOOD; BLOOD CLOT LYSIS; BLOOD COMPONENT; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; DOSE RESPONSE; FIBRINOGENOLYSIS; FIBRINOLYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RABBIT; SNAKE; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA;

AGKISTRODON; ANIMALS; CAROTID ARTERY THROMBOSIS; CROTALID VENOMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; MALE; RABBITS; URINARY PLASMINOGEN ACTIVATOR;

EID: 20444430863     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00099.x     Document Type: Article

References (19)

1. Verstraete M, Lijnen HR, Collen D. Thrombolytic agents in development. Drugs 1995; 50: 29-42.
2. Collen D, Verstraete M. Systematic thrombolytic therapy of acute myocardial infarction. Circulation 1983; 68: 462-5.
3. Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, et al. Thrombolysis in myocardial infarction (TIMI) trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 11: 1-11.
4. Stump DC, Califf RM, Topol EJ, Sigmon K, Thornton D, Masek R, et al. Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator: correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. Circulation 1989; 80: 1222-30.
5. Liang XX, Chen JS, Zhou YN, Qiu PX, Yan GM. Purification and biochemical characterization of FIIa, a fibrinolytic enzyme from Agkistrodon acutus venom. Toxicon 2001; 39: 1133-9.
6. Chen JS, Liang XX, Qiu PX, Yan GM. Thrombolysis effect with FIIa from Agkistrodon acutus venom in different thrombosis model. Acta Pharmacol Sin 2001; 22: 420-2.
7. Chen JS, Liang LG, Sun JJ. The pharmacology characterizations of fibrinolytic fraction II from five-pace snake venom. Chin Pharmacol Bull 1993; 9: 22-5.
8. Gurewich V, Pannell R, Louis S, Kelley P, Robert L, Suddith RL, et al. Effective and fibrin-specific clot lysis by a zymogen precursor from a study in vitro and in tow animal species. J Clin Invest 1984, 73: 1731-9.
9. Wang QC, Xu YL, Liu GF. A simple rabbit carotid thrombus model and the fibrinolytic effect of acutinase. Chin Pharmacol Bull 1993, 9: 228-9.
10. Datta G, Dong A, Witt J, Tu AT. Biochemical characterization of basilase, a fibrinolytic enzyme from Crotalus basiliscus basiliscus. Arch Biochem Biophys 1995, 317: 365-73.
11. Gurewich V, Pannell R. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity. Throm Res 1986, 44: 217-28.
12. Wang QQ, Chen JS, Liang XX, Qiu PX, Wang YW, Yan GM. Hemorrhagic activity and mechanism of FIIa, a fibrinolytic enzyme from Agkistrodon acutus venom. Acta Pharmacol Sin 2004; 25: 514-21.
13. Manning MC. Sequence analysis of fibrolase, a fibrinolytic metalloproteinase from Agkistrodon contortrix contortrix. Toxin 1995; 33: 1189-200.
14. Huang TF, Chang MC, Peng HC, Teng CM. A novel alphatype fibrinogenase from Agkistrodon rhodostoma snake venom. Biophim Biophys Acta 1992; 1160: 262-8.
15. Sugihara H, Mori N, Nikai T, Kishida M, Akagi M. Comparative study of three proteinases from the venom of the Chinese hahu snake (Trimeresurus mucrosquamatus). Comp Biochem Physiol B 1985; 82: 29-35.
16. Estêvão-costa MI, Diniz CR, Magalhães A, Markland FS, Sanchezâ EF. Thromb Res 2000; 99: 363-76.
17. Kamiguti AS, Hay CRM, Zuzel M. Inhibition of collagen-induced platelet aggregation as the result of cleavage at α2β1-integrin by the snake venom metalloproteinase jararhagin. Biochem J 1996; 320: 635-C41.
18. Liu CZ, Huang TF. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridid, prevents platelet-collagen interaction. Arch Biochem Biophys 1997; 337: 291-9.
19. Perutelli P. Disintegrins: potent inhibitors of platelet aggregation. Recent Prog Med 1995; 86: 168-74.